Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Cell Sci ; 129(11): 2156-69, 2016 06 01.
Article in English | MEDLINE | ID: mdl-27068534

ABSTRACT

GPR56 is an adhesion-class G-protein-coupled receptor responsible for bilateral frontoparietal polymicrogyria (BFPP), a severe disorder of cortical formation. Additionally, GPR56 is involved in biological processes as diverse as hematopoietic stem cell generation and maintenance, myoblast fusion, muscle hypertrophy, immunoregulation and tumorigenesis. Collagen III and tissue transglutaminase 2 (TG2) have been revealed as the matricellular ligands of GPR56 involved in BFPP and melanoma development, respectively. In this study, we identify heparin as a glycosaminoglycan interacting partner of GPR56. Analyses of truncated and mutant GPR56 proteins reveal two basic-residue-rich clusters, R(26)GHREDFRFC(35) and L(190)KHPQKASRRP(200), as the major heparin-interacting motifs that overlap partially with the collagen III- and TG2-binding sites. Interestingly, the GPR56-heparin interaction is modulated by collagen III but not TG2, even though both ligands are also heparin-binding proteins. Finally, we show that the interaction with heparin reduces GPR56 receptor shedding, and enhances cell adhesion and motility. These results provide novel insights into the interaction of GPR56 with its multiple endogenous ligands and have functional implications in diseases such as BFPP and cancer.


Subject(s)
Cell Adhesion , Cell Movement , Heparin/metabolism , Receptors, G-Protein-Coupled/metabolism , Amino Acid Sequence , Binding Sites , Cell Line, Tumor , HEK293 Cells , Heparin/chemistry , Humans , Ligands , Membrane Microdomains/metabolism , Neoplasm Invasiveness , Protein Binding , Protein Glutamine gamma Glutamyltransferase 2 , Protein Interaction Mapping , Protein Kinase C-alpha/metabolism , Receptors, G-Protein-Coupled/chemistry , rhoA GTP-Binding Protein/metabolism
2.
J Nanosci Nanotechnol ; 17(4): 2431-437, 2017 Apr.
Article in English | MEDLINE | ID: mdl-29648742

ABSTRACT

The size effect of Au nanoparticles on plasmonic ZnO dye-sensitized cells (DSSCs) was investigated. Different sized Au nanoparticles (~5 nm, 10 nm, and 20 nm) were directly deposited on ZnO nanostructures via an in situ reduction technique. The size and the loading of Au nanoparticle were controlled by varying the amount of reducing agent and the reaction time, respectively. By introducing a proper amount of Au nanoparticles into the photoanode, plasmon-enhanced light absorption, photocurrent and power conversion efficiency were demonstrated, with the enhancement increased with decreasing Au particle size. Overloading the photoanode with Au nanoparticles, however, led to a decline in photocurrent and thus the cell efficiency. Au/ZnO DSSCs with optimized film thickness and 5 nm-Au loading attained an efficiency of 3.49%, corresponding to a 59% improvement over that of pure ZnO DSSCs. The improvement in cell efficiency was ascribed to a significant increase in the photocurrent of Au/ZnO devices, as a result of enhanced light harvesting and reduced interfacial resistance in the photoanode.

3.
Protein Expr Purif ; 109: 85-92, 2015 May.
Article in English | MEDLINE | ID: mdl-25437104

ABSTRACT

GPR56 is a multi-functional adhesion-class G protein-coupled receptor involved in biological systems as diverse as brain development, male gonad development, myoblast fusion, hematopoietic stem cell maintenance, tumor growth and metastasis, and immune-regulation. Ectodomain shedding of human GPR56 receptor has been demonstrated previously, however the quantitative detection of GPR56 receptor shedding has not been investigated fully due to the lack of appropriate assays. Herein, an efficient system of expression and immune-affinity purification of the recombinant soluble extracellular domain of human GPR56 (sGPR56) protein from a stably transduced human melanoma cell line was established. The identity and functionality of the recombinant human sGPR56 protein were verified by Western blotting and mass spectrometry, and ligand-binding assays, respectively. Combined with the use of two recently generated anti-GPR56 monoclonal antibodies, a sensitive sandwich ELISA assay was successfully developed for the quantitative detection of human sGPR56 molecule. We found that GPR56 receptor shedding occurred constitutively and was further increased in activated human melanoma cells expressing endogenous GPR56. In conclusion, we report herein an efficient system for the production and purification of human sGPR56 protein for the establishment of a quantitative ELISA analysis of GPR56 receptor shedding.


Subject(s)
Chromatography, Affinity/methods , Enzyme-Linked Immunosorbent Assay/methods , Receptors, G-Protein-Coupled/isolation & purification , Recombinant Proteins/isolation & purification , Amino Acid Sequence , Animals , Cell Line , Electrophoresis, Polyacrylamide Gel , Genetic Vectors/metabolism , Humans , Ligands , Mass Spectrometry , Mice , Molecular Sequence Data , Receptors, G-Protein-Coupled/chemistry , Recombinant Proteins/chemistry , Retroviridae/metabolism , Solubility
4.
J Invest Dermatol ; 137(3): 727-736, 2017 03.
Article in English | MEDLINE | ID: mdl-27818281

ABSTRACT

GPR56/ADGRG1 is a versatile adhesion G protein-coupled receptor with diverse biological functions. GPR56 expression is variably detected in human melanoma cell lines and correlates inversely with the metastatic potential of melanoma lesions. GPR56 associates with the tetraspanins CD9 and CD81 on the melanoma cell surface. GPR56 activation by immobilized CG4 monoclonal antibody facilitates N-terminal fragment dissociation in a CD9/CD81-dependent manner specifically inducing IL-6 production, which promotes cell migration and invasion. Interestingly, expression of GPR56-C-terminal fragment alone recapitulates the antibody-induced receptor function, implicating a major role for the C-terminal fragment in GPR56 activation and signaling. Analysis of site-directed mutant receptors attests the importance of the conserved N-terminal residues of the C-terminal fragment for its self-activation. Finally, we show that the GPR56-induced signaling in melanoma cells is mediated by the Gα12/13/RhoA pathway. In summary, the expression and activation of GPR56 may modulate melanoma progression in part by inducing IL-6 production after N-terminal fragment dissociation and C-terminal fragment self-activation.


Subject(s)
GTP-Binding Protein alpha Subunits, G12-G13/metabolism , Melanoma/metabolism , Receptors, G-Protein-Coupled/metabolism , rhoA GTP-Binding Protein/metabolism , Cell Line, Tumor , Cell Movement , Humans , Protein Domains , Signal Transduction , Skin Neoplasms/metabolism , Tetraspanin 28/metabolism , Tetraspanin 29/metabolism
5.
Cell Rep ; 15(8): 1757-70, 2016 05 24.
Article in English | MEDLINE | ID: mdl-27184850

ABSTRACT

Natural killer (NK) cells possess potent cytotoxic mechanisms that need to be tightly controlled. Here, we explored the regulation and function of GPR56/ADGRG1, an adhesion G protein-coupled receptor implicated in developmental processes and expressed distinctively in mature NK cells. Expression of GPR56 was triggered by Hobit (a homolog of Blimp-1 in T cells) and declined upon cell activation. Through studying NK cells from polymicrogyria patients with disease-causing mutations in ADGRG1, encoding GPR56, and NK-92 cells ectopically expressing the receptor, we found that GPR56 negatively regulates immediate effector functions, including production of inflammatory cytokines and cytolytic proteins, degranulation, and target cell killing. GPR56 pursues this activity by associating with the tetraspanin CD81. We conclude that GPR56 inhibits natural cytotoxicity of human NK cells.


Subject(s)
Killer Cells, Natural/metabolism , Receptors, G-Protein-Coupled/metabolism , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Line , Cells, Cultured , Cytokines/pharmacology , Cytotoxicity, Immunologic/drug effects , Down-Regulation/drug effects , Humans , Immunological Synapses/drug effects , Inflammation Mediators/metabolism , Killer Cells, Natural/cytology , Killer Cells, Natural/drug effects , Malformations of Cortical Development/pathology , Receptors, G-Protein-Coupled/deficiency , Tetraspanin 28/metabolism , Transcription Factors/metabolism
6.
J Leukoc Biol ; 90(4): 735-40, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21724806

ABSTRACT

We here report the existence of a new cluster of adhesion-GPCRs in human immune cells. Analysis of a comprehensive immune cell transcriptome dataset indicated that expression of the closely related receptors, GPR56, GPR97, and GPR114, is associated with single lymphocyte and granulocyte subsets. Applying flow cytometric analysis with newly generated mAb, we show that expression of GPR56 is restricted to cytotoxic NK and T lymphocytes, including CD8(+), CD4(+), and γδ T cells. Primary infection with human CMV, which generates a vast population of CD8(+) T cells with an effector phenotype, induced a strong increase in GPR56 expression in virus-specific CD8(+) T cells that remained detectable during latency. In NK-92 cells, ectopic expression of GPR56 inhibited spontaneous and SDF-1-stimulated cell migration. Our data suggest that GPR56 expression is a common trait of human cytotoxic lymphocytes and might affect the migratory properties of these cells.


Subject(s)
CD8-Positive T-Lymphocytes/metabolism , Cell Movement , Gene Expression Regulation , Killer Cells, Natural/metabolism , Receptors, G-Protein-Coupled/biosynthesis , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/immunology , Cytomegalovirus/immunology , Cytomegalovirus/metabolism , Cytomegalovirus Infections/immunology , Cytomegalovirus Infections/metabolism , Flow Cytometry , Humans , Killer Cells, Natural/immunology , Receptors, G-Protein-Coupled/immunology
SELECTION OF CITATIONS
SEARCH DETAIL